Carcinoma, Renal Cell: all 1,992 studies

Page 12 of 20. Open to participants first (387), then studies with results posted, then the rest; newest registration first within each.

• First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid TumoursCompletedNCT04504669Phase 1
• Anesthesia and Cancer Study: Renal Cell CarcinomaActive, not recruitingNCT04503148Not applicable
• Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported OutcomesCompletedNCT04501913
• Evaluation of Safety, Biodistibution and Sensitivity/Specificity of PET/CT Imaging With 89Zr-TLX250 in Subjects With RCCCompletedNCT04496089Phase 1
• A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment Naïve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC)CompletedNCT04495257Phase 1
• TTX-080 HLA-G Antagonist in Subjects With Advanced CancersActive, not recruitingNCT04485013Phase 1
• Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney CancerTerminatedNCT04473781Phase 1
• Participant Reported Outcomes and Treatment Experiences in Kidney CancerCompletedNCT04472663
• Cancer and Blood Pressure Management, CARISMA StudyActive, not recruitingNCT04467021Not applicable
• Prospective Translational Study Investigating Possible Molecular prEdictors of Resistance to First-Line pazopanIbCompletedNCT04462445Phase 2
• Study of PF-07265807 in Participants With Metastatic Solid Tumors.TerminatedNCT04458259Phase 1
• A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced MalignanciesCompletedNCT04440943Phase 1
• A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma (COBALT-RCC)TerminatedNCT04438083Phase 1
• Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected PrimaryTerminatedNCT04429321Phase 1
• Assessing the Utility of Ultrasound Compared to Cross-Sectional Imaging in the Follow-up of Patients With Renal Cell CarcinomaStatus unknownNCT04424472Not applicable
• Cabozantinib in the Elderly With Metastatic Renal Cell CarcinomaCompletedNCT04416646
• Identification of Predictive Gene Expression Profile of Sunitinib Response in Metastatic Clear Cell Renal CarcinomasCompletedNCT04415697
• Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCCActive, not recruitingNCT04413123Phase 2
• The Incidence of Pulmonary Embolism During NephrectomyCompletedNCT04402749
• Image Guided RFA/MWA/CRYO of RCC Biomarker Profile StudyStatus unknownNCT04392076
• DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell CancersActive, not recruitingNCT04388852Phase 1
• Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell CarcinomaActive, not recruitingNCT04387500Phase 2
• Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell CarcinomaStatus unknownNCT04385654Phase 2
• Cellular Immunity and Renal Cell CancerCompletedNCT04377113
• Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid TumorsCompletedNCT04374877Phase 1
• Sunitinib Treatment on Tissue Sodium Accumulation (TSS2)CompletedNCT04368546
• Study Of Cabozantinib Treatment In Patients With Unresectable, Locally Advanced Or Metastatic Renal Cell Carcinoma Who Progressed After Previous Treatment With Checkpoint InhibitorsCompletedNCT04353765
• Renal Cell Carcinoma and Stage IV Inferior Vena Cava Thrombus: Resection Without ThoracotomyCompletedNCT04350047
• To Establish a Reproducible Organoid Culture Model With Human Kidney CancerCompletedNCT04342286
• Investigating Marrow Infiltrating Lymphocytes in Renal Cell CarcinomaTerminatedNCT04341740Not applicable
• CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase InhibitionActive, not recruitingNCT04322955Phase 2
• Ketogenic Diet for Patients Receiving Treatment for Metastatic Renal Cell CarcinomaCompletedNCT04316520Not applicable
• Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell CarcinomaTerminatedNCT04300140Phase 1/2
• KIDSTAGE- Staging of Kidney Cancer Using Dual Time PET/CT and Other BiomarkersCompletedNCT04295174
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid TumorsTerminatedNCT04272034Phase 1
• Immune Related-adverse Events in Patients Receiving Immune Checkpoint InhibitorsStatus unknownNCT04268368
• The CAPER Trial: A Phase Ib Clinical Trial of Cyclophosphamide And PEmbrolizumab in Metastatic Renal Cell CarcinomaStatus unknownNCT04262427Phase 1/2
• A Phase 2 Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTIONWithdrawnNCT04262375Phase 2
• A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersTerminatedNCT04260802Phase 1/2
• Trial of NanoDoce Intratumoral Injection in Renal Cell CarcinomaWithdrawnNCT04260360Phase 1
• Onco-primary Care Networking to Support TEAM-based CareActive, not recruitingNCT04258813Not applicable
• Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal TumorsActive, not recruitingNCT04258462Phase 2
• Surgical Treatment of Pancreatic Metastases From Renal Cell CarcinomaStatus unknownNCT04245410
• Residual Normal Renal Parenchymal and Tumor Volume in Tumor SurgeriesStatus unknownNCT04244136
• Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary MalignanciesActive, not recruitingNCT04235777Phase 1
• Uro-DNA Collection for Expanded Genome-Wide Association Study (GWAS) of Renal Cell Carcinoma (RCC)CompletedNCT04222374
• Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma.Status unknownNCT04213664
• Laparoscopic Partial Nephrectomy for cT1 TumorsCompletedNCT04213157
• Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell CarcinomaTerminatedNCT04203901Phase 2
• Safety and Efficacy of Tag-7 Gene-modified Vaccine in Locally Advanced or Metastatic Malignant Melanoma or Kidney CancerCompletedNCT04180774Phase 1/2
• Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain ReliefStatus unknownNCT04177056Not applicable
• Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell CarcinomaCompletedNCT04169711Phase 1
• Preventing Toxicity in Renal Cancer Patients Treated With Immunotherapy Using Fecal Microbiota TransplantationActive, not recruitingNCT04163289Phase 1
• Appropriate Dosing to Optimise Personalised Cancer TreatmentsCompletedNCT04154163
• Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer TissuesActive, not recruitingNCT04147494Early Phase 1
• CaboCHECK - Cabozantinib in Adult Patients With Advanced Renal Cell Carcinoma Following Prior Systemic Check Point Inhibition Therapy: a Retrospective, Non-interventional StudyTerminatedNCT04147143
• Sintilimab in FH-deficient Renal Cell CarcinomaStatus unknownNCT04146831Phase 2
• Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid TumorsStatus unknownNCT04142931Phase 1
• Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCActive, not recruitingNCT04140526Phase 1/2
• Study of Cabozantinib Efficacy, Safety and Tolerability in Metastatic Renal Carcinoma in Aged Fragile Patients: CABOMAYOR StudyCompletedNCT04134390Phase 2
• Nivolumab and Ipilimumab in T1aN0M0 Renal Cell Carcinoma Patients Ineligible for Surgical Treatment.Status unknownNCT04134182Phase 2
• Low-moderate Intensity Pedaling During Immunotherapy AdministrationWithdrawnNCT04127318Not applicable
• Toripalimab Combined With Axitinib as Neoadjuvant Therapy in Patients With Non-metastatic Locally Advanced Nonmetastatic Clear Cell Renal Cell CarcinomaCompletedNCT04118855Phase 2
• Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC)Active, not recruitingNCT04106349
• Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular ImmunotherapyTerminatedNCT04106167
• Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid TumorApproved for marketingNCT04100694
• Normotonic Partial Nephrectomy as Novel Approach in Treating Small Renal MassesCompletedNCT04096534Not applicable
• SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney CancerCompletedNCT04090710Phase 2
• Indocyanine Green (ICG) Guided Tumor ResectionCompletedNCT04084067Phase 1
• Prospective Trial for Examining Hematuria Using Computed TomographyCompletedNCT04077359Not applicable
• Study of ARRY-614 Plus Either Nivolumab or Nivolumab+IpilimumabActive, not recruitingNCT04074967Phase 1/2
• Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL StudyActive, not recruitingNCT04071223Phase 2
• Identification of Novel Biomarkers of Response to Systemic Treatments in Renal Cell CancerStatus unknownNCT04060537
• Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell CarcinomaStatus unknownNCT04049344Phase 2
• A Study of Nivolumab Plus Ipilimumab in Participants With Renal Cell Cancer in the Real World Setting in JapanCompletedNCT04043975
• Fecal Microbiota Transplantation in Diarrhea Induced by Tyrosine-kinase InhibitorsCompletedNCT04040712Not applicable
• Patient Reported Outcome After Nephron Sparing Treatment of Small Renal TumoursActive, not recruitingNCT04040530
• A Study of Combination Spartalizumab and Canakinumab in Patients With Localized Clear Cell Renal Cell CarcinomaCompletedNCT04028245Early Phase 1
• 89Zr-DFO-Atezolizumab ImmunoPET/CT in Patients With Locally Advanced or Metastatic Renal Cell CarcinomaActive, not recruitingNCT04006522Phase 2
• AURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCCCompletedNCT04006405
• Renal Cell Carcinoma Microenvironment Discovery ProjectCompletedNCT04005183
• Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell CarcinomaStatus unknownNCT03987698Phase 2
• Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.Active, not recruitingNCT03983954Phase 1
• Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain MetastasesCompletedNCT03967522Phase 2
• Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell CarcinomaActive, not recruitingNCT03961698Phase 2
• FAZA PET IMAGING IN DETECTING LYMPH NODE METASTASES IN RENAL CELL CARCINOMA PATIENTSCompletedNCT03955393
• Effect on Pre-operative Anxiety of a Personalized Three-dimensional Kidney Model Prior to Nephron-sparing Surgery for Renal Tumor.WithdrawnNCT03943771Not applicable
• MEtatastic Renal Carcinoma LINesStatus unknownNCT03928964
• PAC-1 for Treatment of Refractory, Metastatic Kidney CancerWithdrawnNCT03927248Phase 1/2
• A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell CarcinomaTerminatedNCT03905889Phase 1
• a Prospective Trial Comparing Robot-assisted Partial Nephrectomy Versus Laparoscopic Partial NephrectomyCompletedNCT03900364Not applicable
• The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Status unknownNCT03896958
• Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK Interactions to Predict and Improve EfficacyCompletedNCT03891485
• A Single Arm, Open-label,Phase Ib Study of CT053PTSA in Preciously Treated Patients With Advanced and Metastatic RCCTerminatedNCT03876925Phase 1/2
• Tazemetostat Expanded Access Program for Adults With Solid TumorsNo longer availableNCT03874455
• A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney CancerActive, not recruitingNCT03873402Phase 3
• A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid TumorsCompletedNCT03872947Phase 1
• Development of a Cabozantinib (Cabometyx) Symptom Management Application for Use in Patients With Renal CancerTerminatedNCT03867045Not applicable
• Mind-Body Health in Uro-Oncology: Research StudyCompletedNCT03852030Not applicable
• A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid TumorsActive, not recruitingNCT03845166Phase 1

← Carcinoma, Renal Cell overview